Our study demonstrated that Vδ2 T cells express a variety of chemokine receptors and that the expression levels of CCR4, CCR7, CCR8, CXCR1 and CX3CR1 on Vδ2 T cells are upregulated in new-onset SLE patients. This evidence concerns the gene CX3CR1 and systemic lupus erythematosus.